References
- Vincent PC. Drug-induced aplastic anaemia and agranulocytosis: incidence and mechanisms. Drags 1986: 31(1): 52–63
- Heimpel H. Drug-induced agranulocytosis. Med Toxicol Adverse Drug Exp 1988: 3(6): 449–62
- Young GA, Vincent PC. Drug-induced agranulocytosis. Clin Haematol 1980: 9(3): 483–504
- Pisciotta V. Drug-induced agranulocytosis. Drugs 1978: 15(2): 132–43
- Meyers DG, Gonzalez ER, Peters LL, et al. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations. Am Heart J 1985: 109(6): 1393–5
- Ellrodt AG, Murata GH, Riedinger MS, et al. Severe neutropenia associated with sustained-release procainamide. Ann Intern Med 1984: 100(2): 197–201
- Nagesh KG, Poulose KP, Tseng TH, et al. Procainamide-induced agranulocytosis: report of two cases and review. J Kans Med Soc 1980: 81 (1): 18–24
- Drugs for cardiac arrhythmias. Med Lett Drugs Ther 1989: 31(790): 35–40
- Cruickshank JM, Prichard BN. Beta-blockers in clinical practice. New York: Longman (Churchill Livingstone), 1987: 850
- Pisciotta AV, Cronkite G Aprindine-induced agranulocytosis: evidence for immunologic mechanism. Arch Intern Med 1983: 143(2): 241–3
- Taetle R, Lane TA, Mendelsohn J. Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibody. Blood 1979: 54(2): 501–12
- Samlowski WE, Frame RN, Logue GL. Flecanide-induced immune neutropenia: documentation of a hapten-mediated mechanism of cell destruction. Arch Intern Med 1987: 147(2): 383–4
- Volosin K, Greenberg RM, Greenspon AJ. Tocainide associated agranulocytosis. Am Heart J 1985: 109(6): 1392–3
- Oliphant LD, Goddard M. Tocainide-associated neutropenia and lupus-like syndrome. Chest 1988: 94(2): 427–8
- Kelton JG, Huang AT, Mold N, et al. The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med 1979: 301 (12): 621–4
- Sutherland R, Vincent PC, Raik E, et al. Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. BMJ 1977: 1 (6061): 605–7
- Pido PA. Combating infection in neutropenic patients. Hosp Pract [Off] 1989: 24(7): 93–110
- Muroi K, I to M, Sasaki R, et al. Treatment of drug-induced agranulocytosis with granulocyte-colony stimulating factor. (Letter) Lancet 1989: 2(8653): 55
- Delannoy A, Gehenot M. Colony-stimulating factor and drug-induced agranulocytosis. (Letter) Ann Intern Med 1989: 110(11): 942–3